These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 31703679
1. Total saponins of Bolbostemma paniculatum (maxim.) Franquet exert antitumor activity against MDA-MB-231 human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway. Dou JW, Shang RG, Lei XQ, Li KL, Guo ZZ, Ye K, Yang XJ, Li YW, Zhou YY, Yao J, Huang Q. BMC Complement Altern Med; 2019 Nov 08; 19(1):304. PubMed ID: 31703679 [Abstract] [Full Text] [Related]
2. Bolbostemma paniculatum (Maxim.) Franquet extract suppresses the development of colorectal cancer through downregulation of PI3K/Akt pathway. Li Y, Sun Y, Zhang Q, Liu Y, Niu Y, Li X, Cai D. J Ethnopharmacol; 2022 Apr 06; 287():114937. PubMed ID: 34958876 [Abstract] [Full Text] [Related]
3. Effecacy of Biejia (Carapax Trionycis) and Ezhu (Rhizoma Curcumae Phaeocaulis) couplet medicine on epithelial-mesenchymal transition, invasion and migration of MDA-MB-231 triple negative breast cancer cells via PI3K/Akt/mTOR signaling pathway. Zhu MJ, Xie S, Xie Q, Zhu JL, Huang YZ. J Tradit Chin Med; 2021 Dec 06; 41(6):853-861. PubMed ID: 34939381 [Abstract] [Full Text] [Related]
4. A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway. Zhang X, Liu Z, Chen S, Li H, Dong L, Fu X. J Ethnopharmacol; 2022 Jan 30; 283():114742. PubMed ID: 34655668 [Abstract] [Full Text] [Related]
5. Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway. Zhou R, Chen H, Chen J, Chen X, Wen Y, Xu L. BMC Complement Altern Med; 2018 Mar 09; 18(1):83. PubMed ID: 29523109 [Abstract] [Full Text] [Related]
6. Study of the PI3K/Akt/mTOR signaling pathway in vitro and molecular docking analysis of periplocin inhibits cell cycle progression and induces apoptosis in MDA-MB-231. Liu X, Liu J, Yan B, Quan Z, Wang X, Ma Y, Alarfaj AA, Yan L. Environ Toxicol; 2024 Jan 09; 39(1):444-456. PubMed ID: 37792628 [Abstract] [Full Text] [Related]
7. Anti-breast cancer and toxicity studies of total secondary saponin from Anemone raddeana Rhizome on MCF-7 cells via ROS generation and PI3K/AKT/mTOR inactivation. Zhang D, Zhang Q, Zheng Y, Lu J. J Ethnopharmacol; 2020 Sep 15; 259():112984. PubMed ID: 32446927 [Abstract] [Full Text] [Related]
8. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway. Wu C, Qiu S, Liu P, Ge Y, Gao X. J Ethnopharmacol; 2018 Jan 30; 211():89-100. PubMed ID: 28962890 [Abstract] [Full Text] [Related]
9. CLE-10 from Carpesium abrotanoides L. Suppresses the Growth of Human Breast Cancer Cells (MDA-MB-231) In Vitro by Inducing Apoptosis and Pro-Death Autophagy Via the PI3K/Akt/mTOR Signaling Pathway. Tian L, Cheng F, Wang L, Qin W, Zou K, Chen J. Molecules; 2019 Mar 20; 24(6):. PubMed ID: 30897708 [Abstract] [Full Text] [Related]
10. Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines. Wang L, Wu J, Lu J, Ma R, Sun D, Tang J. Mol Med Rep; 2015 Feb 20; 11(2):931-9. PubMed ID: 25355053 [Abstract] [Full Text] [Related]
11. Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231. Xu T, Liu P, Li Q, Shi C, Wang X. Taiwan J Obstet Gynecol; 2020 Nov 20; 59(6):828-834. PubMed ID: 33218396 [Abstract] [Full Text] [Related]
12. Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo. Meng M, Yang Q, Ouyang Z, Yang Q, Wu X, Huang Y, Su Y, Chen S, Chen W. Acta Pharm; 2023 Mar 01; 73(1):75-90. PubMed ID: 36692465 [Abstract] [Full Text] [Related]
13. Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway. Wang LL, Huang WW, Huang J, Huang RF, Li NN, Hong Y, Chen ML, Wu F, Liu J. Kaohsiung J Med Sci; 2020 Aug 01; 36(8):581-591. PubMed ID: 32311203 [Abstract] [Full Text] [Related]
14. Sinomenine inhibits hypoxia induced breast cancer side population cells metastasis by PI3K/Akt/mTOR pathway. Song L, Zhang H, Hu M, Liu C, Zhao Y, Zhang S, Liu D. Bioorg Med Chem; 2021 Feb 01; 31():115986. PubMed ID: 33412412 [Abstract] [Full Text] [Related]
15. Chamomile Essential Oil: Chemical Constituents and Antitumor Activity in MDA-MB-231 Cells through PI3K/Akt/mTOR Signaling Pathway. An Z, Feng X, Sun M, Wang Y, Wang H, Gong Y. Chem Biodivers; 2023 Apr 01; 20(4):e202200523. PubMed ID: 36941224 [Abstract] [Full Text] [Related]
16. Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling. Tohkayomatee R, Reabroi S, Tungmunnithum D, Parichatikanond W, Pinthong D. Molecules; 2022 May 31; 27(11):. PubMed ID: 35684480 [Abstract] [Full Text] [Related]
17. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway. Liu H, Li X, Duan Y, Xie JB, Piao XL. J Ethnopharmacol; 2021 May 10; 271():113907. PubMed ID: 33556477 [Abstract] [Full Text] [Related]
18. Discovery of 1-(3-aryl-4-chlorophenyl)-3-(p-aryl)urea derivatives against breast cancer by inhibiting PI3K/Akt/mTOR and Hedgehog signalings. Li W, Sun Q, Song L, Gao C, Liu F, Chen Y, Jiang Y. Eur J Med Chem; 2017 Dec 01; 141():721-733. PubMed ID: 29107429 [Abstract] [Full Text] [Related]
19. LncRNA MALAT1 Expression Regulates Breast Cancer Progression via PI3K/AKT/mTOR Pathway Modulation. Naveed M, Malik A, Anjum H, Ijaz B. Biochem Genet; 2024 Oct 01; 62(5):3421-3438. PubMed ID: 38110774 [Abstract] [Full Text] [Related]
20. Celastrus Orbiculatus Extracts Inhibit the Metastasis through Attenuating PI3K/Akt/mTOR Signaling Pathway in Human Gastric Cancer. Qian Y, Yan Y, Lu H, Zhou T, Lv M, Fang C, Hou J, Li W, Chen X, Sun H, Li Y, Wang Z, Zhao N, Gu Y, Ding Y, Liu Y. Anticancer Agents Med Chem; 2019 Oct 01; 19(14):1754-1761. PubMed ID: 31364518 [Abstract] [Full Text] [Related] Page: [Next] [New Search]